Article
C/EBPα dysregulation in AML and ALL.
Critical reviews in oncogenesis - 1 Jan 2011
Paz-Priel Ido, Friedman Alan
Abstract excerpt
The transcription factor CCAAT/enhancer binding protein a (C/EBPα) is a critical regulator of myeloid development, directing granulocyte, and monocyte differentiation. As such, it is dysregulated in more than half of patients with acute myeloid leukemia (AML). C/EBPα expression is suppressed as result of common leukemia-associated genetic and epigenetic alterations such as AML1-ETO, BCR-ABL, FLT3-ITD, or CEBPA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
